| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
17,346 |
14,292 |
$964K |
| 80053 |
Comprehensive metabolic panel |
10,897 |
8,842 |
$528K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
11,291 |
8,888 |
$494K |
| 94010 |
|
1,754 |
1,697 |
$414K |
| 36415 |
Collection of venous blood by venipuncture |
7,880 |
4,443 |
$374K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
7,447 |
4,255 |
$346K |
| 81001 |
|
13,028 |
11,371 |
$315K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
3,238 |
2,698 |
$312K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
14,780 |
12,588 |
$292K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
6,496 |
4,958 |
$226K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
7,149 |
6,166 |
$189K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
7,669 |
6,662 |
$178K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
192 |
188 |
$173K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
2,427 |
2,207 |
$155K |
| 81025 |
|
7,387 |
6,661 |
$147K |
| 84702 |
|
2,527 |
2,140 |
$122K |
| 86900 |
|
1,607 |
1,417 |
$113K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
2,048 |
1,701 |
$103K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
3,044 |
2,768 |
$81K |
| 70450 |
Computed tomography, head or brain; without contrast material |
2,608 |
2,366 |
$73K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
2,320 |
2,070 |
$72K |
| 87210 |
|
845 |
778 |
$67K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
176 |
166 |
$60K |
| 71046 |
Radiologic examination, chest; 2 views |
3,046 |
2,691 |
$52K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
337 |
275 |
$52K |
| 71250 |
|
343 |
336 |
$50K |
| 76642 |
|
1,061 |
937 |
$48K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
2,644 |
2,454 |
$43K |
| 85027 |
|
4,668 |
3,723 |
$43K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
1,956 |
1,747 |
$42K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
735 |
545 |
$39K |
| 86850 |
|
823 |
737 |
$38K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
1,257 |
1,206 |
$36K |
| 76830 |
Ultrasound, transvaginal |
356 |
327 |
$35K |
| 82565 |
|
138 |
131 |
$33K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
18,854 |
14,713 |
$31K |
| 86901 |
|
1,732 |
1,542 |
$30K |
| 71045 |
Radiologic examination, chest; single view |
4,326 |
3,699 |
$27K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
866 |
702 |
$26K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
344 |
304 |
$25K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
9,793 |
7,941 |
$25K |
| A4649 |
Surgical supply; miscellaneous |
202 |
142 |
$23K |
| 87077 |
|
994 |
904 |
$21K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
238 |
225 |
$20K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
320 |
292 |
$20K |
| 77066 |
Tomosynthesis, mammo |
259 |
242 |
$19K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
474 |
447 |
$19K |
| 76801 |
|
1,185 |
976 |
$15K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
593 |
542 |
$15K |
| 73560 |
|
453 |
388 |
$14K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
3,185 |
2,933 |
$12K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
4,823 |
3,824 |
$11K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
179 |
167 |
$10K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
9,915 |
8,029 |
$10K |
| G0378 |
Hospital observation service, per hour |
3,236 |
2,079 |
$10K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
14 |
14 |
$10K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
994 |
919 |
$10K |
| 87081 |
|
79 |
68 |
$9K |
| 84112 |
|
42 |
38 |
$8K |
| 94060 |
|
28 |
27 |
$7K |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
2,145 |
1,666 |
$7K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
4,095 |
3,778 |
$7K |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
15 |
15 |
$7K |
| J3490 |
Unclassified drugs |
6,237 |
3,373 |
$7K |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
801 |
618 |
$6K |
| 73630 |
|
104 |
89 |
$6K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
8,658 |
6,857 |
$6K |
| 76937 |
|
784 |
651 |
$6K |
| 81003 |
|
438 |
410 |
$6K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
4,369 |
3,781 |
$5K |
| 94761 |
|
249 |
243 |
$5K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
414 |
382 |
$5K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
14 |
14 |
$4K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
6,826 |
5,242 |
$4K |
| 84484 |
|
5,219 |
3,974 |
$3K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
684 |
593 |
$3K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
150 |
143 |
$3K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
133 |
121 |
$3K |
| J1815 |
Injection, insulin, per 5 units |
769 |
252 |
$3K |
| 73030 |
|
80 |
75 |
$3K |
| 73502 |
|
58 |
50 |
$3K |
| 77065 |
Tomosynthesis, mammo |
84 |
78 |
$2K |
| 85610 |
|
2,049 |
1,662 |
$2K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
1,788 |
1,051 |
$2K |
| 93971 |
|
52 |
50 |
$2K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
254 |
170 |
$2K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
847 |
725 |
$2K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
5,330 |
4,493 |
$2K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
3,259 |
2,513 |
$2K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
18 |
14 |
$1K |
| 76641 |
|
17 |
12 |
$1K |
| C1769 |
Guide wire |
182 |
164 |
$1K |
| 83735 |
|
6,462 |
4,811 |
$1K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
996 |
965 |
$1K |
| 72100 |
|
95 |
91 |
$1K |
| 94664 |
|
63 |
17 |
$1K |
| 84703 |
|
159 |
135 |
$1K |
| 76770 |
|
15 |
12 |
$1K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
139 |
122 |
$980.77 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
15 |
13 |
$958.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
3,099 |
2,520 |
$856.78 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
1,375 |
1,063 |
$849.57 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
2,538 |
1,994 |
$838.72 |
| 85379 |
|
451 |
422 |
$777.36 |
| A9585 |
Injection, gadobutrol, 0.1 ml |
942 |
876 |
$669.80 |
| 84443 |
Thyroid stimulating hormone (TSH) |
953 |
847 |
$667.58 |
| 80076 |
|
173 |
162 |
$602.59 |
| 82570 |
|
132 |
114 |
$430.15 |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
13 |
12 |
$360.51 |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
15 |
12 |
$353.74 |
| 73130 |
|
26 |
24 |
$335.34 |
| A9270 |
Non-covered item or service |
4,578 |
2,409 |
$292.50 |
| 82550 |
|
879 |
605 |
$212.54 |
| 85018 |
|
31 |
25 |
$199.68 |
| 82077 |
|
48 |
45 |
$117.61 |
| 80069 |
|
33 |
28 |
$66.68 |
| 88304 |
|
68 |
60 |
$61.69 |
| J2704 |
Injection, propofol, 10 mg |
543 |
440 |
$23.35 |
| J1596 |
Injection, glycopyrrolate, 0.1 mg |
388 |
325 |
$10.68 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
1,290 |
1,001 |
$2.28 |
| J2060 |
Injection, lorazepam, 2 mg |
110 |
70 |
$0.00 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
2,669 |
1,923 |
$0.00 |
| 82553 |
|
546 |
348 |
$0.00 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
74 |
66 |
$0.00 |
| 96376 |
|
2,084 |
1,203 |
$0.00 |
| 83690 |
|
4,602 |
4,037 |
$0.00 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
621 |
346 |
$0.00 |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
139 |
131 |
$0.00 |
| Q9969 |
Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose |
30 |
29 |
$0.00 |
| 86140 |
|
72 |
69 |
$0.00 |
| 36410 |
|
259 |
227 |
$0.00 |
| 85730 |
|
1,607 |
1,349 |
$0.00 |
| 83880 |
|
1,189 |
1,024 |
$0.00 |
| J2371 |
Injection, phenylephrine hydrochloride, 20 micrograms |
275 |
259 |
$0.00 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
1,003 |
928 |
$0.00 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
4,393 |
3,711 |
$0.00 |
| 83605 |
|
1,148 |
993 |
$0.00 |
| 88342 |
|
277 |
249 |
$0.00 |
| J7050 |
Infusion, normal saline solution, 250 cc |
480 |
311 |
$0.00 |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
563 |
455 |
$0.00 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
283 |
217 |
$0.00 |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
415 |
318 |
$0.00 |
| 88307 |
|
83 |
80 |
$0.00 |
| J1940 |
Injection, furosemide, up to 20 mg |
52 |
37 |
$0.00 |
| 83615 |
|
85 |
80 |
$0.00 |
| J0360 |
Injection, hydralazine hcl, up to 20 mg |
19 |
13 |
$0.00 |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
111 |
110 |
$0.00 |
| J2470 |
Injection, pantoprazole sodium, 40 mg |
29 |
25 |
$0.00 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
117 |
116 |
$0.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
40 |
40 |
$0.00 |
| 87040 |
|
84 |
63 |
$0.00 |
| 86803 |
|
64 |
62 |
$0.00 |
| S0020 |
Injection, bupivicaine hydrochloride, 30 ml |
17 |
14 |
$0.00 |
| J1598 |
Injection, glycopyrrolate (fresenius kabi), not therapeutically equivalent to j1596, 0.1 mg |
50 |
44 |
$0.00 |
| 94729 |
|
147 |
144 |
$0.00 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
523 |
444 |
$0.00 |
| 84550 |
|
134 |
113 |
$0.00 |
| J1644 |
Injection, heparin sodium, per 1000 units |
1,278 |
388 |
$0.00 |
| 94726 |
|
98 |
97 |
$0.00 |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
1,098 |
948 |
$0.00 |
| 93976 |
|
967 |
840 |
$0.00 |
| 87186 |
|
696 |
639 |
$0.00 |
| C9113 |
Injection, pantoprazole sodium, per vial |
190 |
122 |
$0.00 |
| 84145 |
|
128 |
111 |
$0.00 |
| 84156 |
|
132 |
114 |
$0.00 |
| G0279 |
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) |
135 |
132 |
$0.00 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
3,440 |
2,880 |
$0.00 |
| 84100 |
|
492 |
291 |
$0.00 |
| J3370 |
Injection, vancomycin hcl, 500 mg |
226 |
190 |
$0.00 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
162 |
106 |
$0.00 |
| 99152 |
|
31 |
25 |
$0.00 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
177 |
78 |
$0.00 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
81 |
68 |
$0.00 |
| 97161 |
|
62 |
49 |
$0.00 |
| 90715 |
|
13 |
13 |
$0.00 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
69 |
57 |
$0.00 |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
55 |
47 |
$0.00 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
15 |
14 |
$0.00 |
| J2272 |
Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg |
34 |
24 |
$0.00 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
78 |
57 |
$0.00 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
26 |
24 |
$0.00 |
| 85014 |
|
21 |
12 |
$0.00 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
32 |
24 |
$0.00 |
| J2274 |
Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg |
34 |
26 |
$0.00 |